Medicare Enrolled
Dr. Beeran Meghpara, M.D.
Ophthalmology · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meghpara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meghpara?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meghpara
Dr. Beeran Meghpara is an ophthalmology specialist in Philadelphia, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Meghpara performed 1,403 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Meghpara received a total of $329,621 from 43 pharmaceutical and/or device companies across 668 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meghpara is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ 1,403 Medicare services
$329,621 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,403
Medicare services
Bottom 43% in PA for ophthalmology
Not available
Unique patients (not deduplicated)
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
390 | $94 | $171 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
253 | $21 | $109 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
162 | $382 | $1,964 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $69 | $117 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
74 | $106 | $228 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
70 | $28 | $64 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $131 | $243 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
49 | $31 | $150 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
38 | $8 | $25 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
36 | $66 | $144 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
30 | $263 | $808 |
| Corneal transplant, outer layer Surgical procedure to replace the outer layer of the cornea with donor tissue. |
28 | $982 | $2,536 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
28 | $30 | $62 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
25 | $94 | $198 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
15 | $30 | $103 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
11 | $626 | $1,750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.5% high complexity
10.8% medium
75.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$329,621
Total received (2018-2024)
Avg $47,089/year across 7 years
Top 1% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
668
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$84,773
2023
$61,549
2022
$114,223
2021
$44,198
2020
$16,997
2019
$6,682
2018
$1,201
Payments by company (2024)
Johnson & Johnson Surgical Vision, Inc.
$37,705
SUN PHARMACEUTICAL INDUSTRIES INC.
$14,944
Dompe US, Inc.
$10,292
Glaukos Corporation
$9,837
Thea Pharma Inc.
$4,393
ABBVIE INC.
$1,341
BIOTISSUE HOLDINGS INC.
$1,135
Nordic Pharma, Inc.
$1,025
Sight Sciences, Inc.
$913
Carl Zeiss Meditec USA, Inc.
$780
Alcon Vision LLC
$589
Carl Zeiss Meditec, Inc.
$519
W. L. Gore & Associates, Inc.
$440
Tarsus Pharmaceuticals, Inc.
$192
Harrow Eye, LLC
$190
Johnson & Johnson Vision Care, Inc.
$171
Oyster Point Pharma, Inc.
$131
Ortho-Clinical Diagnostics, Inc.
$123
Bausch & Lomb Americas Inc.
$33
ANI Pharmaceuticals, Inc.
$20
Top 3 companies account for 74.2% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Surgical Vision, Inc.
$57,717
Sun Pharmaceutical Industries Inc.
$40,267
Dompe US, Inc.
$30,051
EYEVANCE PHARMACEUTICALS LLC
$29,596
Eyevance Pharmaceuticals LLC
$28,762
SUN PHARMACEUTICAL INDUSTRIES INC.
$27,469
Allergan, Inc.
$27,119
ABBVIE INC.
$22,468
Glaukos Corporation
$12,041
Kala Pharmaceuticals, Inc.
$9,158
Sight Sciences, Inc.
$8,724
GLAUKOS CORPORATION
$7,250
W. L. Gore & Associates, Inc.
$6,380
Thea Pharma Inc.
$5,898
OCULUS, Inc.
$2,750
BioTissue Holdings, Inc.
$2,646
Carl Zeiss Meditec, Inc.
$1,583
Ocular Therapeutix, Inc.
$1,572
Alcon Vision LLC
$1,196
BIOTISSUE HOLDINGS INC.
$1,135
Nordic Pharma, Inc.
$1,025
Carl Zeiss Meditec USA, Inc.
$950
Oyster Point Pharma, Inc.
$540
TissueTech, Inc.
$527
Novartis Pharmaceuticals Corporation
$410
Bausch & Lomb, a division of Bausch Health US, LLC
$371
Allergan Inc.
$357
Bausch & Lomb Americas Inc.
$279
Tarsus Pharmaceuticals, Inc.
$192
Harrow Eye, LLC
$190
Johnson & Johnson Vision Care, Inc.
$171
RxSight Inc
$140
TISSUETECH, INC.
$140
Ortho-Clinical Diagnostics, Inc.
$123
Bausch Health US, LLC
$102
BIOTISSUE HOLDINGS, INC.
$84
Mallinckrodt Hospital Products Inc.
$79
Shire North American Group Inc
$63
NEW WORLD MEDICAL,INC.
$33
ANI Pharmaceuticals, Inc.
$20
Carl Zeiss Meditec AG
$19
Oasis Medical, Inc.
$12
EyePoint Pharmaceuticals US, Inc.
$12
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARTEVO 800 · AcrySof · Acuvue · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS 6000 with AngioPlex · CIRRUS HD-OCT · CLARUS 700 · Centurion · Cequa · Clareon · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · EYSUVIS · FORUM · Flarex · IDESIGN RS · IFS ADVANCED FEMTOSEC LASER · ILINK · ILUX · INVELTYS · IOLMaster 700 · IYUZEH · InflammaDry · KXL System · KXL system (not refurbished) · Kahook Dual Blade · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · Lacrifill · MIEBO · NGENUITY · None Specified · OXERVATE · OZURDEX · Oasis TEARS · One Series Ultra · Oxervate · PAZEO · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Pentacam · Product in Development · Prokera · QUATERA 700 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSure Sealant · STELLARIS · Simbrinza · TEARCARE SYSTEM · TECNIS IOL · TYRVAYA · TearCare SmartLid · Tecnis IOL · Tecnis Simplicity · Tecnis Symfony IOL · TobraDex ST · Tobradex ST · VERACITY SURGICAL · VERITAS Vision System · VEVYE · VUITY · VYZULTA · VisuMax · XDEMVY · XELPROS · XIIDRA · Zerviate · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System Model G2-M-IS
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
531
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meghpara is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meghpara experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Meghpara performed 390 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Meghpara receive payments from pharmaceutical companies?
Yes. Dr. Meghpara received a total of $329,621 from 43 companies across 668 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meghpara's costs compare to other ophthalmologists in Philadelphia?
Dr. Meghpara's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meghpara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Philadelphia
Browse ophthalmologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in PA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in PA
Which PA ophthalmologists receive the most from drug and device companies.
By company
Johnson & Johnson Surgical Vision, Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Surgical Vision, Inc.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
By company
Dompe US, Inc. Payments to Doctors
See all physicians who received payments from Dompe US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology